BOLD-100 triggered ER stress in a variety of cancer and resistant cell lines but not normal cells, and in xenograft studies suppressed GRP78 upregulation by BRAF inhibitor in the tumor with no effect on GRP78 expression in adjacent normal cells (95). The gene discussed is BRAF; the disease is cancer.